Log In
BCIQ
Print this Print this
 

eFT508

  Manage Alerts
Collapse Summary General Information
Company Effector Therapeutics Inc.
DescriptionSmall molecule inhibitor of MAP kinase interacting serine-threonine kinase 1 (MKNK1; MNK1) and MKNK2 (MNK2)
Molecular Target MAP kinase interacting serine-threonine kinase 1 (MKNK1) (MNK1) ; MAP kinase interacting serine-threonine kinase 2 (MKNK2) (MNK2)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I/II
Standard IndicationSolid tumors
Indication DetailsTreat advanced solid tumors
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today